MOUNJARO 2.5MG/0.5ML INJECTION

How MOUNJARO 2.5MG/0.5ML INJECTION Works

• Tirzepatide activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. These incretin pathways can increase insulin release when glucose is high, reduce glucagon secretion, slow gastric emptying and influence appetite. These effects support glucose control, but may also cause nausea, vomiting, diarrhoea, constipation or abdominal discomfort. Delayed gastric emptying can affect absorption of some oral medicines. The exact response differs between people, so glucose monitoring and clinical follow-up remain important. Product-specific vial preparation and injection instructions must be taken from the Indian pack leaflet.

Common effects include nausea, diarrhoea, reduced appetite, vomiting, constipation and abdominal discomfort. Serious concerns include pancreatitis, gallbladder problems, dehydration with kidney injury, severe allergic reaction and low blood glucose when combined with insulin or a sulfonylurea. Seek urgent care for persistent severe abdominal pain, breathing difficulty, facial swelling or severe hypoglycaemia.

• Nausea
• Diarrhoea
• Reduced appetite
• Vomiting
• Constipation
• Abdominal discomfort
• Pancreatitis
• Gallbladder problems
• Dehydration
• Low blood glucose
• Allergic reaction

• Follow the storage conditions printed on the current Indian carton and vial leaflet. The exact Indian pack storage statement was not verified in the cached listing. Protect the vial from freezing and excess heat, keep it away from children, and do not use a damaged, expired or improperly stored pack. Ask the dispensing pharmacist how to handle a vial after removal from its original storage conditions.

• Confirm the vial presentation and instructions from the Indian pack.
• Keep all follow-up and glucose monitoring appointments.
• Report persistent vomiting, diarrhoea or severe abdominal pain.
• Tell the clinician about insulin and sulfonylurea use.
• Do not share needles or injection equipment.
• Check the listing status with a pharmacist before supply.

• No special food restriction was verified for the specific Indian vial. Nutrition advice should follow the diabetes care plan. Tirzepatide delays gastric emptying and may affect absorption of some oral medicines; the prescriber should review medicines with a narrow therapeutic range. Alcohol and missed meals can complicate glucose control, especially with insulin or sulfonylureas. Ask the diabetes team for individualized advice and do not change food or medicine plans without review.